Real progress means moving beyond short-term control toward long-term change
In obese mice, semaglutide treatment improved lipid metabolism, reduced oxidative stress and inflammation, decreased lipid peroxidation, and protected cardiac functions [97]
As mentioned, GIP was the first hormone identified to have incretin activity, but its failure in diabetic patients left an open question: what other gut factor accounts for the incretin effect
[PubMed] [PMC] Cibelli A, Stout R, Timmermann A, De Menezes L, Guo P, Maass K, Seifert G, Steinhuser C, Spray DC, Scemes E (2021) Cx43 carboxyl terminal domain determines AQP4 and Cx30 endfoot organization and blood brain barrier permeability
But what is the optimal dose for this peptide
[DOI] [Google Scholar] Nahar K, Hasanuzzaman M, Alam MM, Fujita M